Publication Name	World Journal of Gastroenterology
Manuscript ID	103156
Country	Egypt

Received	2024-11-11 02:28
Peer-Review Started	2024-11-11 02:29
To Make the First Decision
Return for Revision	2025-02-07 20:33
Revised	2025-02-16 17:02
Second Decision	2025-03-12 02:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-03-12 05:29
Articles in Press	2025-03-12 05:29
Publication Fee Transferred
Edit the Manuscript by Language Editor	2025-03-24 12:03
Typeset the Manuscript	2025-04-23 07:59
Publish the Manuscript Online	2025-04-29 09:13

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Vonoprazan and proton pump inhibitors: Which is superior for Helicobacter pylori eradication?
Manuscript Source	Invited Manuscript
All Author List	Mubin Ozercan, Ahmed Tawheed, Alaa Ismail, Mohab Sherif Amer and Mohamed El-Kassas
ORCID	Author(s) ORCID Number Mubin Ozercan http://orcid.org/0000-0002-6968-7838 Ahmed Tawheed http://orcid.org/0000-0002-9382-8733 Alaa Ismail http://orcid.org/0000-0002-7314-9311 Mohab Sherif Amer http://orcid.org/0000-0003-3474-5433 Mohamed El-Kassas http://orcid.org/0000-0002-3396-6894
Funding Agency and Grant Number
Corresponding Author	Mohamed El-Kassas, Department of Endemic Medicine, Helwan University, Ain Helwan, Cairo 11795, Egypt. m_elkassas@hq.helwan.edu.eg
Key Words	Vonoprazan; Proton pump inhibitors; Helicobacter pylori; Potassium competitive acid blockers; Acid related disorders
Core Tip	In this article, we summarize the current evidence regarding the better choice between proton pump inhibitors and vonoprazan for treating a very common global disease like Helicobacter pylori. We also comment on a recently published article by Gao et al, where the authors provided real-life experiences managing Helicobacter pylori in the elderly using vonoprazan.
Publish Date	2025-04-29 09:13
Citation	<p>Ozercan M, Tawheed A, Ismail A, Amer MS, El-Kassas M. Vonoprazan and proton pump inhibitors: Which is superior for Helicobacter pylori eradication? <i>World J Gastroenterol</i> 2025; 31(17): 103156</p>
URL	https://www.wjgnet.com/1007-9327/full/v31/i17/103156.htm
DOI	https://dx.doi.org/10.3748/wjg.v31.i17.103156

Full Article (PDF)	WJG-31-103156-with-cover.pdf
Manuscript File	103156_Auto_Edited_060600.docx
Answering Reviewers	103156-answering-reviewers.pdf
Audio Core Tip	103156-audio.mp3
Conflict-of-Interest Disclosure Form	103156-conflict-of-interest-statement.pdf
Copyright License Agreement	103156-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	103156-non-native-speakers.pdf
Peer-review Report	103156-peer-reviews.pdf
Scientific Misconduct Check	103156-scientific-misconduct-check.png
Scientific Editor Work List	103156-scientific-editor-work-list.pdf
CrossCheck Report	103156-crosscheck-report.pdf